Tag: Valerie Daggett

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease, researchers show

Posted on by Heinsius
A team led by MolES faculty member and bioengineering Professor Valerie Daggett has developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer's disease. Dylan Shea, a molecular engineering PhD student in the Daggett lab, was the lead author on a new paper describing these findings, published April 19 in the Proceedings of the National Academy of Sciences.